Market Cap
$55.63 Billion
USD as of July 1, 2024
Company | Market Cap (USD) |
---|---|
![]() |
$178.02 B |
![]() |
$126.48 B |
![]() |
$112.32 B |
![]() |
$98.95 B |
![]() |
$47.37 B |
Company | Market Cap (USD) |
---|---|
![]() |
$808.65 B |
![]() |
$622.07 B |
![]() |
$450.89 B |
![]() |
$350.63 B |
![]() |
$318.75 B |
Top 1-year algo backtest: +207.50%
$10,000 in July 2023 would now be $30,750 by following this algorithm daily at market close.
Boost your investing & swing trading... Now!
Try Disfold DeepFinance FREE
Edwards Lifesciences Corporation is a medical technology company specialized in artificial heart valves and hemodynamic monitoring. Edwards Lifesciences designs, manufactures, and markets surgical valve technologies, transcatheter heart valves, transcatheter mitral and tricuspid therapies, and critical care catheters.
Edwards Lifesciences Corporation has the following listings and related stock indices.
Stock: NYSE: EW
Stock: BMV: EW
Stock: Bovespa: E1WL34
Stock: FSX: EWL
Stock: XETR: EWL
The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.